For the millions of adults who struggle to meet formal exercise guidelines, the staircase may represent one of the most accessible cardiovascular interventions hiding in plain sight. A large aggregated dataset now quantifies what smaller studies have hinted at: a single low-cost daily behavior is meaningfully linked to reduced risk of dying from heart disease — and the effect size is substantial enough to deserve serious clinical attention.
This systematic review and meta-analysis, published in the American Journal of Cardiovascular Drugs, pooled data from nine studies encompassing 480,479 participants drawn from PubMed and Embase databases through April 2025. The headline finding: stair climbing was associated with a 39% relative reduction in cardiovascular mortality (RR 0.61, 95% CI 0.48–0.79, p = 0.0002) across five studies involving 455,619 individuals. All-cause mortality was also significantly lower among stair climbers, with a relative risk of 0.76 (95% CI 0.62–0.94, p = 0.01). Cardiovascular morbidity outcomes — including myocardial infarction, ischemic stroke, and heart failure incidence — showed further associations, though the excerpt does not fully detail the effect sizes for each endpoint.
This finding sits within a growing body of evidence supporting incidental physical activity — movement embedded in daily routines rather than structured exercise sessions — as a meaningful driver of cardiovascular health. Prior research on stair climbing has demonstrated acute improvements in VO₂ max, blood pressure, and lipid profiles, but population-level mortality data has been scattered. The strength here is the cohort size: nearly half a million participants gives the pooled relative risk genuine statistical weight. Key limitations remain, however. The majority of included studies are observational, meaning residual confounding — such as the fact that healthier, more mobile individuals may climb stairs more — cannot be ruled out. Reverse causation is also plausible. The heterogeneity across studies in how "stair climbing" was defined and measured adds further uncertainty. Still, as a low-barrier, no-cost behavior with a plausible physiological mechanism and a large effect size, this meta-analysis is an incremental but practically significant addition to the lifestyle medicine evidence base.
